BIONIK LABORATORIES CORP. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/20a4a38e-978e-4c8f-ad58-535d4602507c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-4.8M | 2022-04-01 – 2023-03-31 | evidence 0001410578-23-001453 |
| FY 2021 | $-10.0M | 2021-04-01 – 2022-03-31 | evidence 0001410578-22-001865 |
| FY 2020 | $-13.3M | 2020-04-01 – 2021-03-31 | evidence 0001104659-21-084897 |
| FY 2019 | $-25.1M | 2019-04-01 – 2020-03-31 | evidence 0001104659-21-084897 |
| FY 2013 | $-1.5M | 2013-04-01 – 2014-03-31 | evidence 0001144204-15-033664 |
| FY 2012 | $-937.1k | 2012-04-01 – 2013-03-31 | evidence 0001144204-15-033664 |
| FY 2011 | $-4.5k | 2011-01-01 – 2011-12-31 | evidence 0001014897-12-000081 |
| FY 2010 | $-8.1k | 2010-01-08 – 2010-12-31 | evidence 0001014897-12-000081 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BIONIK LABORATORIES CORP. — all facts · Revenue · Net Income